Author:
De Koster E.,Ntounda R.,Clicque C.,De Bruyne I.,Langlet P.,Jonas C.,Deltenre M.
Subject
Radiology, Nuclear Medicine and imaging
Reference76 articles.
1. DE KOSTER E., JONAS C., FERHAT M., DENIS P., BUSET M., DELTENRE M.—Should HelicobacterHelicobacter pylori be eradicated before starting a long term proton pump inhibitor treatment for reflux oesophagitis?Acta Endoscopica, 1997,27, 201–11.
2. JONES D.M., ELDRIDGE J., FOX A.J.et al.—Antibody to the gastric campylobacter-like organism (‘Campylobacter pyloridis’): Clinical correlations and distribution in the normal population.J. Med. Microbiol., 1986,22, 57–62.
3. AGNHOLT J., FALLINGBORG J., MOLLER-PETERSEN J., LOMBORG S., CHRISTENSEN L.A., SONDERGAARD G., TEGLBJAERG P.S., RASMUSSEN S.N.— The occurrence ofHelicobacter pylori in the oesophagus.Eur. J. Gastroenterol. Hepatol., 1991,3, 685–688.
4. ROSIORU C., GLASSMAN M.S., HALATA M.S., SCHWARZ SM.—Esophagitis andHelicobacter pylori in children: Incidence and therapeutic implication.Am. J. Gastroenterol., 1993,88, 510–513.
5. O'CONNOR H.J., CUNNANE K.—Helicobacter pylori and gastro-oesophageal reflux disease-a prospective study.Ir. J. Med. Sci., 1994,163, 369–73.